Paris-Dakner Nanolifesciences Private Limited - Company Profile

It is a pharma private limited company based in Madurai, Tamil Nadu, India, established in 2009.
2009 Madurai, Tamil Nadu, India Active
Last Updated:
Access Report
About Paris-Dakner Nanolifesciences Private Limited

Paris-Dakner Nanolifesciences Private Limited, a active private limited company, was established on 26 August 2009 in Madurai, Tamil Nadu, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U15323TN2009PTC072701. Registered under ROC Roc Chennai. it is unlisted. It has an authorized capital of ₹2.50 M and a paid-up capital of ₹0.10 M.

Formerly known as Glorex Medicare Private Limited. It upholds a active non-compliant status. Its leadership includes Sathish Kumar Muthupillai (Managing Director), Mohanasundram Madhumathi (Additional Director), Vignesh Mohanasundaram (Additional Director). Past directors included Anandvivek Bajpai, Arumugam Rathakrishnan, Mohanasundaram Umarani. It holds ₹0.17 M open charges and no settled loans. Its latest AGM occurred on 30 September 2013, with the balance sheet filed on 31 March 2013. It is based at Shed No:56, Mahia Industrial Area, Uranganpatti,, Madurai, Tamil Nadu, 625020.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U15323TN2009PTC072701

  • Registration Number

    072701

  • Incorporation Date

    26 August 2009

  • Authorized Capital

    ₹2.50 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Chennai

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 2.50 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 16 Year, 6 Months
  • Last Filing with ROC 31 Mar 2013
  • Open Charges ₹ 0.17 M
Company report

Paris-Dakner Nanolifesciences Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Paris-Dakner Nanolifesciences Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Paris-Dakner Nanolifesciences Private Limited?
Current Directors
Name Designation Appointment Date Status
Sathish Kumar Muthupillai Managing Director 01 Feb 2014 Current
Mohanasundram Madhumathi Additional Director 25 Mar 2014 Current
Vignesh Mohanasundaram Additional Director 29 Mar 2014 Current
Kunasekaran Arun Pradeep Additional Director 29 Mar 2014 Current
Anandvivek Bajpai Director 14 Jun 2013 Current
Mohanasundaram Umarani Director 14 Jun 2013 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 30 Sep 2013 Past
Pramod Abcsdd Director 10 Jan 2010 Past
Pramod Abcsdd Additional Director 30 Sep 2013 Past
Pramod Abcsdd Director 17 Jun 2013 Past
Pramod Abcsdd Director 17 Jun 2013 Past
Pramod Abcsdd Managing Director 17 Jun 2013 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Paris-Dakner Nanolifesciences.

Enhance accessibility to Paris-Dakner Nanolifesciences's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Paris-Dakner Nanolifesciences revenue growth over time
Paris-Dakner Nanolifesciences profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Paris-Dakner Nanolifesciences?

Unlock access to Paris-Dakner Nanolifesciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹170,000.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions
  • Indian Overseas Bank : 0.02 Cr
Latest Charge Details
Date Lender Amount Status
17 Mar 2010 Indian Overseas Bank ₹0.17 M Open

Explore comprehensive loan charge details -

How Many Employees Work at Paris-Dakner Nanolifesciences?

Unlock and access historical data on people associated with Paris-Dakner Nanolifesciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Paris-Dakner Nanolifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Paris-Dakner Nanolifesciences's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Paris-Dakner Nanolifesciences
Recent Activity within the Organization
  • Director Appointment

    Vignesh Mohanasundaram was appointed as a Additional Director was appointed as a Additional Director on 29 Mar 2014 & has been associated with this company since 11 years 11 months . was recorded as a recent event.

  • Director Appointment

    Progress on Kunasekaran Arun Pradeep was appointed as a Additional Director was appointed as a Additional Director on 29 Mar 2014 & has been associated with this company since 11 years 11 months . was documented.

  • Director Appointment

    Mohanasundram Madhumathi was appointed as a Additional Director was appointed as a Additional Director on 25 Mar 2014 & has been associated with this company since 11 years 11 months . was recorded as a recent event.

  • Director Appointment

    Progress on Sathish Kumar Muthupillai was appointed as a Managing Director was appointed as a Managing Director on 01 Feb 2014 & has been associated with this company since 12 years 25 days . was documented.

  • Annual General Meeting

    The activity Paris-Dakner Nanolifesciences Private Limited last Annual general meeting of members was held on 30 Sep 2013 as per latest MCA records. was completed.

  • Director Appointment

    The activity Anandvivek Bajpai was appointed as a Director was appointed as a Director on 14 Jun 2013 & has been associated with this company since 12 years 8 months . was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Paris-Dakner Nanolifesciences Private Limited?

The CIN of Paris-Dakner Nanolifesciences Private Limited is U15323TN2009PTC072701.

Where is Paris-Dakner Nanolifesciences Private Limited headquartered?

Paris-Dakner Nanolifesciences Private Limited is headquartered at Shed No:56, Mahia Industrial Area, Uranganpatti,, Madurai, Tamil Nadu, 625020.

When was Paris-Dakner Nanolifesciences Private Limited incorporated?

Paris-Dakner Nanolifesciences Private Limited was incorporated on 26 August 2009.

Who are the current directors of Paris-Dakner Nanolifesciences Private Limited?

The current directors of Paris-Dakner Nanolifesciences Private Limited are

What is the primary industry of Paris-Dakner Nanolifesciences Private Limited?

The primary industry of Paris-Dakner Nanolifesciences Private Limited is Pharma.

Is Paris-Dakner Nanolifesciences Private Limited a listed company?

Paris-Dakner Nanolifesciences Private Limited is unlisted.

What is the capital structure of Paris-Dakner Nanolifesciences Private Limited?

The authorized capital of Paris-Dakner Nanolifesciences Private Limited is ₹2.50 M, and the paid-up capital is ₹0.10 M.

What is the compliance status of Paris-Dakner Nanolifesciences Private Limited?

The compliance status of Paris-Dakner Nanolifesciences Private Limited is Active Non-Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available